Article
Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, Aβ and tau neuropathology in the triple-transgenic mice.
Molecular psychiatry - 1 Nov 2015
Chu J, Li J-G, Giannopoulos P F, Blass B E, Childers W, Abou-Gharbia M, Praticò D
Abstract excerpt
The 12/15-lipoxygenase (12/15LO) enzyme is widely distributed within the central nervous system. Previous work showed that this protein is upregulated in Alzheimer's disease (AD), and plays an active role in the development of brain amyloidosis in amyloid beta (Aβ)-precursor protein transgenic mice (Tg2576). In the present paper, we studied the effect of its pharmacologic inhibition on the AD-like phenotype of a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
